Prognostic Value of Synaptophysin and Chromogranin A Expression in Patients Receiving Palliative Chemotherapy for Advanced Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0356|85|4|289-296

ISSN： 0025-7931

Source： Respiration, Vol.85, Iss.4, 2012-04, pp. : 289-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Drugs in the Palliative Chemotherapy of Advanced Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 416-421

Karger

Access to resources Recommend Favorite

Palliative Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Goals and Reality

By  

Oncology Research and Treatment, Vol. 22, Iss. 1, 1999-03 ,pp. : 63-64

Karger

Access to resources Recommend Favorite

Inflammation‐Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First‐Line Chemotherapy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 3, 2014-09 ,pp. : 360-369

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patients of all ages with advanced non‐small cell lung cancer are not receiving chemotherapy

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 5, 2015-09 ,pp. : 337-338

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemotherapy in Non-Small Cell Lung Cancer Patients Receiving Oxygen Therapy

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 587-590

Karger

Access to resources Recommend Favorite